Loading organizations...
Key people at Scopus Ventures.
Scopus Ventures is an early-stage venture capital firm in Los Angeles, California, investing in enterprise software companies. It provides capital and strategic support to businesses developing transformative technologies. Beyond funding, the firm assists portfolio companies with operational support in marketing, talent acquisition, and strategic guidance.
Established in 2016, Scopus Ventures was co-founded by Managing Partner Bahram Nour-Omid. His prior venture capital background highlighted the need for a hands-on approach, combining capital with operational assistance. This insight shaped the firm’s focus on early-stage enterprise software ventures, providing a more comprehensive partnership for nascent companies.
The firm supports ambitious entrepreneurs leading nascent enterprise software companies. Scopus Ventures’ vision is to empower these ventures, transforming innovative ideas into market-leading products. They aim to foster the next generation of enterprise technology leaders, guiding them from development to achieving significant market presence.
Scopus Ventures is a Los Angeles-based early-stage venture capital firm founded in 2016 that invests primarily in technology and healthcare sectors across the US, Israel, and Asia. Their mission centers on backing scalable, automation-driven technology startups with innovative solutions, aiming to foster growth in cutting-edge industries. The firm emphasizes a founder-focused investment philosophy, partnering closely with entrepreneurs to accelerate their ventures and impact the startup ecosystem by providing capital, strategic guidance, and access to a broad network[1][3][4][5].
The firm was established by visionary entrepreneurs and investors, including key partners such as Bahram Nour-Omid (Chairman and Managing Partner), Eran Gilad, and Robert Mai (Managing Partners), and Arnaud Gregori (COO). Scopus Ventures evolved with a focus on delivering tailored investment programs that integrate private markets infrastructure and data-driven tools, enabling efficient fund formation and portfolio management. Their approach is designed to overcome legacy private market challenges by avoiding compensation from fund managers, thus maintaining an undiluted focus on quality investments and client alignment[2][5].
Scopus Ventures rides the wave of automation-driven technology and healthcare innovation, sectors experiencing rapid growth due to digital transformation and increasing demand for scalable tech solutions. The timing is favorable given the global push towards automation, AI, and healthcare tech advancements. By investing early in these sectors, Scopus Ventures influences the ecosystem by enabling startups to scale and innovate, contributing to the evolution of private markets with a more transparent, data-driven investment model[1][4][5].
Looking ahead, Scopus Ventures is poised to deepen its impact by expanding its portfolio in automation and healthcare tech, leveraging its founder-centric approach and advanced investment infrastructure. Trends such as AI, machine learning, and digital health will likely shape their investment focus, enhancing their influence in shaping next-generation technology startups. Their commitment to reinventing private investing and maintaining alignment with founders and clients positions them well for sustained growth and ecosystem leadership[2][5].
Key people at Scopus Ventures.
Scopus Ventures has 17 tracked investments across 11 companies. The latest tracked deal is $30.0M Series B in Rivery.io in May 2022.
